新型冠状病毒疫苗接种后发生的Sweet综合征
Sweet Syndrome Following SARS-CoV2 Vaccination.
作者信息
Baffa Maria Efenesia, Maglie Roberto, Giovannozzi Neri, Montefusco Francesca, Senatore Stefano, Massi Daniela, Antiga Emiliano
机构信息
Department of Health Sciences, Section of Dermatology, University of Florence, 50125 Florence, Italy.
Department of Health Sciences, Section of Pathological Anatomy, University of Florence, 50139 Florence, Italy.
出版信息
Vaccines (Basel). 2021 Oct 20;9(11):1212. doi: 10.3390/vaccines9111212.
Abstract
Vaccines are today considered one of the most effective means against the Sars-CoV-2 pandemic. The BNT162b2 vaccine by Pfizer/BioNTech has been massively administered throughout the globe; since its approval, a wide spectrum of cutaneous reactions has been reported. Here we report the case of a 52-year-old Caucasian male who presented with an acute febrile eruption that arose 72 h after the first dose of the BNT162b2 vaccine. The clinicopathological findings were consistent with Sweet's syndrome. The short latency time suggested a possible role of the vaccine in triggering Sweet's syndrome in this case.
摘要
如今，疫苗被认为是对抗新冠疫情最有效的手段之一。辉瑞/ BioNTech公司的BNT162b2疫苗已在全球范围内大量接种；自获批以来，已报告了广泛的皮肤反应。在此，我们报告一例52岁的白种男性病例，其在接种第一剂BNT162b2疫苗72小时后出现急性发热性皮疹。临床病理结果符合Sweet综合征。较短的潜伏期表明在该病例中疫苗可能触发了Sweet综合征。
相似文献
1
Sweet Syndrome Following SARS-CoV2 Vaccination.新型冠状病毒疫苗接种后发生的Sweet综合征
Vaccines (Basel). 2021 Oct 20;9(11):1212. doi: 10.3390/vaccines9111212.
2
Sweet's syndrome following surgery: cutaneous trauma as a possible aetiological co-factor in neutrophilic dermatoses.手术后的Sweet综合征：皮肤创伤作为嗜中性皮病可能的病因辅助因素
Australas J Dermatol. 2015 Aug;56(3):e74-6. doi: 10.1111/ajd.12142. Epub 2014 Mar 11.
3
Proton pump inhibitor-induced Sweet's syndrome: report of acute febrile neutrophilic dermatosis in a woman with recurrent breast cancer.质子泵抑制剂诱发的Sweet综合征：一名复发性乳腺癌女性急性发热性嗜中性皮病的病例报告
Dermatol Pract Concept. 2015 Apr 30;5(2):113-9. doi: 10.5826/dpc.0502a23. eCollection 2015 Apr.
4
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
5
A Case of Acute Pulmonary Embolus after mRNA SARS-CoV-2 Immunization.1例新型冠状病毒mRNA疫苗接种后急性肺栓塞病例
Vaccines (Basel). 2021 Aug 14;9(8):903. doi: 10.3390/vaccines9080903.
6
A neutrophilic reaction of Sweet's syndrome type associated with the oral contraceptive.与口服避孕药相关的Sweet综合征类型的嗜中性粒细胞反应。
Australas J Dermatol. 1991;32(1):55-9. doi: 10.1111/j.1440-0960.1991.tb00684.x.
7
Serum cytokine profile in pediatric Sweet's syndrome: a case report.儿童Sweet综合征的血清细胞因子谱：病例报告
J Med Case Rep. 2017 Jul 2;11(1):178. doi: 10.1186/s13256-017-1317-0.
8
Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet's syndrome.甲氧苄啶-磺胺甲恶唑相关急性发热性嗜中性皮病：病例报告及药物性Sweet综合征综述
J Am Acad Dermatol. 1996 May;34(5 Pt 2):918-23. doi: 10.1016/s0190-9622(96)90080-8.
9
[Acute febrile neutrophilic dermatosis and malignant hematologic diseases: report of a new bullous case and review of the literature].[急性发热性嗜中性皮病与恶性血液病：1例新发大疱性病例报告及文献复习]
Ann Dermatol Venereol. 1988;115(6-7):689-701.
10
Case Report of Sweet's Syndrome Associated With Autoimmune Hepatitis.伴自身免疫性肝炎的Sweet综合征病例报告
J Cutan Med Surg. 2017 Jan/Feb;21(1):72-74. doi: 10.1177/1203475416665602. Epub 2016 Aug 20.
引用本文的文献
1
Molecular Characteristics of Sweet Syndrome: A Systematic Review.Sweet综合征的分子特征：一项系统综述
Exp Dermatol. 2024 Dec;33(12):e70022. doi: 10.1111/exd.70022.
2
Recurrent giant cellulitis-like Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine.由新冠病毒辉瑞-生物科技mRNA疫苗诱发的复发性巨细胞性蜂窝织炎样斯威特综合征
Dermatol Reports. 2023 May 23;15(3):9668. doi: 10.4081/dr.2023.9668. eCollection 2023 Sep 12.
3
Sweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studies.新冠病毒疫苗引起的Sweet 综合征：患者报告研究的系统评价。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2217076. doi: 10.1080/21645515.2023.2217076.
4
Shedding Light on Novel Pathogenic and Therapeutic Aspects Related to Immune-Mediated Skin Diseases.揭示免疫介导性皮肤病相关的新致病和治疗方面
Vaccines (Basel). 2023 Mar 29;11(4):761. doi: 10.3390/vaccines11040761.
5
Vesiculobullous and Other Cutaneous Manifestations of COVID-19 Vaccines: a Scoping and Narrative Review.COVID-19 疫苗的水疱性和其他皮肤表现：范围界定和叙述性综述。
J Cutan Med Surg. 2023 May-Jun;27(3):260-270. doi: 10.1177/12034754231156561. Epub 2023 Feb 15.
6
Atypical presentation of Sweet syndrome with nodular erythema and oral ulcerations provoked by Ad26.COV2.S SARS-CoV-2 vaccination and review of literature.Ad26.COV2.S 疫苗接种引起的 Sweet 综合征伴结节性红斑和口腔溃疡的非典型表现，并复习文献。
Dermatol Ther. 2022 Dec;35(12):e15923. doi: 10.1111/dth.15923. Epub 2022 Oct 23.
7
Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.接种 COVID-19 疫苗后的自身免疫和自身炎症性疾病。新病例报告和最新文献回顾。
J Autoimmun. 2022 Oct;132:102898. doi: 10.1016/j.jaut.2022.102898. Epub 2022 Aug 24.
8
Sweet syndrome following Moderna COVID-19 vaccine: A case report.接种莫德纳新冠疫苗后出现Sweet综合征：一例报告。
SAGE Open Med Case Rep. 2022 Aug 11;10:2050313X221117884. doi: 10.1177/2050313X221117884. eCollection 2022.
9
Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis.新冠病毒疫苗接种后皮肤不良反应的全球流行率和临床表现：系统评价和荟萃分析。
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1947-1968. doi: 10.1111/jdv.18294. Epub 2022 Jun 21.
10
Cutaneous reactions to COVID-19 vaccines: A review.新型冠状病毒肺炎疫苗的皮肤反应：综述
JAAD Int. 2022 Jun;7:178-186. doi: 10.1016/j.jdin.2022.01.011. Epub 2022 Feb 17.
本文引用的文献
1
Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine.mRNA-1273疫苗接种后出现急性脑炎、肌阵挛和Sweet综合征。
BMJ Case Rep. 2021 Jul 26;14(7):e243173. doi: 10.1136/bcr-2021-243173.
2
Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.接种 COVID-19 疫苗后迟发性皮肤不良反应的临床和组织病理学谱。
J Cutan Pathol. 2022 Jan;49(1):34-41. doi: 10.1111/cup.14104. Epub 2021 Aug 8.
3
AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report.阿斯利康（AZD1222）新冠疫苗相关药品不良事件：一例病例报告。
J Med Virol. 2021 Oct;93(10):5718-5720. doi: 10.1002/jmv.27175. Epub 2021 Jul 8.
4
Sweet's Syndrome Three Weeks after a Severe COVID-19 Infection: A Case Report.重症 COVID-19 感染三周后出现的Sweet综合征：一例报告
Acta Derm Venereol. 2021 Jun 30;101(6):adv00486. doi: 10.2340/00015555-3850.
5
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine.由新冠病毒辉瑞-BioNTech信使核糖核酸疫苗诱发的Sweet综合征。
Allergy. 2021 Oct;76(10):3194-3196. doi: 10.1111/all.14981. Epub 2021 Jul 3.
6
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination.27名受试者在接种mRNA/DNA新冠病毒疫苗后出现免疫介导疾病发作或新发疾病
Vaccines (Basel). 2021 Apr 29;9(5):435. doi: 10.3390/vaccines9050435.
7
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.报告的 Moderna 和辉瑞 COVID-19 疫苗接种后皮肤反应：基于登记的 414 例病例研究。
J Am Acad Dermatol. 2021 Jul;85(1):46-55. doi: 10.1016/j.jaad.2021.03.092. Epub 2021 Apr 7.
8
COVID-19 vaccines: modes of immune activation and future challenges.COVID-19 疫苗：免疫激活模式和未来挑战。
Nat Rev Immunol. 2021 Apr;21(4):195-197. doi: 10.1038/s41577-021-00526-x.
9
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
10
Coronavirus 19 presenting with atypical Sweet's syndrome.表现为非典型斯威特综合征的新型冠状病毒肺炎
J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e534-e535. doi: 10.1111/jdv.16662. Epub 2020 Jun 29.
Zotero 插件